Skip to main content

Advertisement

Table 1 Baseline characteristics

From: Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study

  Insulin-naïve type 2 diabetic patients (n = 73) Insulin-treated type 2 diabetic patients (n = 57) p
Mean age ± SD (yrs) 56.0 ± 8.9 55.6 ± 8.7 .824
% female (number) 31.5 (23) 38.6 (22) .399
Mean disease duration ± SD (yrs) 6.8 ± 5.0 12.7 ± 7.2 < .001
Mean HbA1c ± SD (%) 8.8 ± 1.6 8.5 ± 1.6 .455
Mean BMI ± SD (kg/m 2 ) 32.6 ± 6.0 35.7 ± 7.9 .0.17
# of complications 1 0.6 ± 1.0 1.4 ± 1.3 < .001
Mean ITAS ± SD (total score) 50.0 ± 10.8 45.8 ± 8.3 .013
Mean negative ITAS ± SD 41.3 ± 10.4 37.4 ± 7.6 .016
Mean positive ITAS ± SD 9.9 ± 2.3 9.4 ± 1.9 .175
Mean PAID ± SD 31.4 ± 18.3 28.2 ± 14.1 .257
Mean WHO-5 ± SD 14.7 ± 6.3 12.9 ± 6.4 .115
Mean CES-D ± SD 14.4 ± 9.7 17.8 ± 10.9 .072
Mean Trait Anxiety ± SD 39.9 ± 11.3 41.6 ± 8.4 .334
  1. 1Retinopathy, nephropathy, diabetic neuropathy, diabetic foot syndrome, coronary heart disease, stroke, arterial occlusive disease